Stock ALNFL NFL BIOSCIENCES
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases NFL Biosciences

Equities

ALNFL

FR0014003XT0

Real-time Euronext Paris
Other stock markets
 07:46:30 2024-06-20 EDT 		5-day change 1st Jan Change
2.36 EUR +3.06% Intraday chart for NFL Biosciences +3.96% +63.89%
05-29 NFL Biosciences: study with CEA presented at congress CF
05-21 NFL Biosciences receives positive feedback from the FDA CF

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NFL BIOSCIENCES : publication scientifique de l'étude sur le mécanisme d'action de NFL-101 menée par le CEA dans ACS Chemical Neuroscience
PU
NFL BIOSCIENCES: Scientific publication of the study on the mechanism of action of NFL-101 conducted by the CEA in ACS Chemical Neuroscience
PU
NFL BIOSCIENCES : présentation des résultats de l'étude menée avec le CEA, au congrès de l'Albatros
PU
NFL BIOSCIENCES : Presentation of the study results conducted with the CEA at the Albatross congress
PU
NFL BIOSCIENCES : RETOUR POSITIF DE LA FDA SUR LA DEMANDE DE PRE IND POUR NFL 301 DÉDIÉ À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL
PU
NFL BIOSCIENCES: POSITIVE FDA RESPONSE FOLLOWING THE PRE IND APPLICATION FOR NFL 301 FOR REDUCING ALCOHOL CONSUMPTION
PU
NFL Biosciences : Assemblée générale mixte du 30 mai 2024
PU
NFL Biosciences : further strengthens its operational team with the arrival of a Head of Development and Manufacturing
PU
NFL Biosciences : renforce son équipe opérationnelle avec l’arrivée d’une Responsable du développement et de la fabrication
PU
NFL Biosciences : Successful capital increase for NFL Biosciences with over €3 million raised
PU
NFL Biosciences : launches a fundraising round for 3 million euros through a capital increase
PU
NFL Biosciences : lance une levée de fonds d’environ 3 millions d’euros par voie d’augmentations de capital
PU
NFL BIOSCIENCES : SHOWCASES THE RESULTS OF ITS STUDIES TO THE SCIENTIFIC AND PHARMACEUTICAL COMMUNITIES
PU
NFL BIOSCIENCES : VALORISE SES RÉSULTATS D’ÉTUDES AUPRÈS DE LA COMMUNAUTÉ SCIENTIFIQUE ET PHARMACEUTIQUE
PU
NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS ANNUELS 2023
PU
NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
PU
NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
PU
NFL Biosciences : PRE-IND application filed with the FDA in the United States for NFL-301, indicated for reducing alcohol consumption
PU
NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA AUX ÉTATS-UNIS POUR NFL- 301 DÉDIÉ À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL
PU
NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALNFL Stock
  4. News NFL Biosciences
  5. Press Releases